Drug intelligence / Profile preview

Revanesse

Development stage
Unknown
Lead developer
Prollenium Medical Technologies
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Intradermal, Subcutaneous, Submucosal
01

Overview

Revanesse is a brand of hyaluronic acid-based dermal fillers used for cosmetic purposes. The primary active ingredient is hyaluronic acid, a naturally occurring polysaccharide found in the human body that helps maintain skin hydration and volume. In the context of dermal fillers, hyaluronic acid is produced by bacterial fermentation and then purified for use as an injectable soft tissue filler. The mechanism of action involves injection into facial tissues to restore volume, smooth moderate to severe wrinkles and folds (such as nasolabial folds), or augment lips. Some formulations (e.g., Revanesse Lips+) are crosslinked with 1,4-butanediol diglycidyl ether (BDDE) to enhance stability and longevity; certain products also contain lidocaine for pain reduction during injection[2][3][4]. Revanesse products are FDA approved for adults aged 22 years or older seeking correction of facial wrinkles/creases or lip augmentation[2][3][4]. Results typically last up to one year.

Brand names
RevanesseRevanesse VersaRevanesse UltraRevanesse Lips+Revanesse Versa+

Beyond the preview

Go deeper on Revanesse.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Revanesse.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call